Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NR1 in Chronic Ischemic Subcortical Stroke
NCT04631406Phase 2Active, not recruiting
- Sponsor
- Clarion Cells
- Start
- Jan 2021
- Primary completion
- Aug 2025
- Countries
- 1
01
Overview
A Phase 2 trial of CC-101 in ischemic stroke, sponsored by Clarion Cells. Started Jan 2021; status: active, not recruiting.
02
Drugs
CC-101
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04631406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631406.